Total Funding
37
13
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
305985
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.
- Michael Brines: Co-Founder and Chief Science Officer
- Anthony Cerami: Founder
About the Company
Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases. Its lead compound, ARA 290, a novel 11 amino acid peptide, stimulates tissue protective, reparative, and anti-inflammatory signaling pathways through selective IRR activation.
Araim Pharmaceuticals is based in Tarrytown,
New York.
